📰 Leukemia News
Page 160 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
May 26, 2022
Over the past decade, researchers have made great strides in the development and administration of cancer immunotherapies, which use the body's own immune system to treat disease.
May 26, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 25, 2022
TIBSOVO is the first therapy targeting cancer metabolism approved in combination with azacitidine for patients with newly diagnosed IDH1-mutated acute myeloid leukemia FDA approval based
May 24, 2022
Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To "Avidity Enhancement" AMSTERDAM, May 24, 2022 /PRNewswire/ -- LUMICKS, a leading
May 20, 2022
Tri-cities area in eastern washington that are running out of it completely. some of them posting signs that all they have left is diesel, sometimes unleaded, but while the supply is eventually replenished, the demand is as high as the price is and it is putting a strain on people like kenneth, who was diagnosed with leukemia and travels in his home in eastern washington to seattle three times a month for medical care, and unfortunately, those trips are costing him and his wife around $120 each ...
May 20, 2022
Adolescent and young adult (AYA) survivors of leukemia have a life span that is about 10% lower than that of their peers in the general population.
May 20, 2022
Tri-cities area in eastern washington that are running out of it completely. some of them posting signs that all they have left is diesel, sometimes unleaded, but while the supply is eventually replenished, the demand is as high as the price is and it is putting a strain on people like kenneth, who was diagnosed with leukemia and travels in his home in eastern washington to seattle three times a month for medical care, and unfortunately, those trips are costing him and his wife around $120 each ...
May 18, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 18, 2022
In a new study, researchers evaluated the BNT162b2 coronavirus disease 2019 mRNA vaccine (antigen)-specific immune response among myeloid dysplastic syndrome and chronic lymphocytic leukemia patients.
May 17, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.